Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Transplant Hepatology
What is your approach to discussions with patients about the MELD score, its use for prognostication of outcomes and decompensation?
Related Questions
What cardiac testing do you perform for patients undergoing liver transplant evaluation?
How do you approach risk of development of PTLD in liver transplant recipients with positive EBV antibodies and/or viral loads?
What is your strategy to manage peri-procedural bleeding risk in patients with cirrhosis?
Should a patient who requires definitive treatment for prostate cancer as a pre-transplant requirement be strictly required to complete their course prior to transplant/initiation of immunosuppression?
With an increase in the prevalence of MASLD in the United States population, what recipient and donor characteristics do you find favorable for acceptance of a highly steatotic graft?
Is there a serum ammonium level for which you recommend initiation of dialysis in a patient with hepatic encephalopathy?
What is your strategy to manage the complication of long-term immunosuppression in liver transplant recipients, specifically renal dysfunction and onset of cardiometabolic comorbidities?
Are there any specific guidelines for the transplantation of metastatic disease to the liver or are these institution specific?
How much do you factor in a patient's frailty in selection for transplant if the underlying driver for their debility is their underlying liver disease itself?
How do you counsel patients on the use of marginal organs and/or high risk donors who are on the liver transplant wait list?
